OBJECTIVE: We aimed to estimate the cost saving (over the next 10 years) by our trust implementing the new British Society of Gastroenterology (BSG) surveillance guidelines for Barrett's oesophagus (BO). DESIGN: Retrospective endoscopy database analysis. SETTING: Two endoscopy units of St George's Hospital NHS Trust, London. PATIENTS: Gastroscopy records between 2009 and 2012 were retrieved and patients with an endoscopic diagnosis of BO were identified. BO segment length was recorded and the presence (or absence) of intestinal metaplasia in the oesophageal biopsy samples was reviewed from pathology databases. Patients were then stratified into risk groups in accordance with the new BSG guidelines. INTERVENTIONS: Nil. MAIN OUTCOME MEASURES: The projected surveillance costs using the new and the old guidelines were calculated over the next 10 years and the cost saving by the implementation of the new guidelines thus determined. RESULTS: The 10 year projected cost saving for our trust by implementing the new BO surveillance guidelines was £720 330 (or £72 033 per annum). Projected across the NHS, implementation of the new guidance may save £100 million over the next 10 years. CONCLUSIONS: All trusts should review their Barrett's surveillance population and implement these new recommendations expeditiously.
OBJECTIVE: We aimed to estimate the cost saving (over the next 10 years) by our trust implementing the new British Society of Gastroenterology (BSG) surveillance guidelines for Barrett's oesophagus (BO). DESIGN: Retrospective endoscopy database analysis. SETTING: Two endoscopy units of St George's Hospital NHS Trust, London. PATIENTS: Gastroscopy records between 2009 and 2012 were retrieved and patients with an endoscopic diagnosis of BO were identified. BO segment length was recorded and the presence (or absence) of intestinal metaplasia in the oesophageal biopsy samples was reviewed from pathology databases. Patients were then stratified into risk groups in accordance with the new BSG guidelines. INTERVENTIONS: Nil. MAIN OUTCOME MEASURES: The projected surveillance costs using the new and the old guidelines were calculated over the next 10 years and the cost saving by the implementation of the new guidelines thus determined. RESULTS: The 10 year projected cost saving for our trust by implementing the new BO surveillance guidelines was £720 330 (or £72 033 per annum). Projected across the NHS, implementation of the new guidance may save £100 million over the next 10 years. CONCLUSIONS: All trusts should review their Barrett's surveillance population and implement these new recommendations expeditiously.
Authors: Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen Journal: Gastroenterology Date: 2011-03 Impact factor: 22.682
Authors: Rehan J Haidry; Jason M Dunn; Mohammed A Butt; Matthew G Burnell; Abhinav Gupta; Sarah Green; Haroon Miah; Howard L Smart; Pradeep Bhandari; Lesley Ann Smith; Robert Willert; Grant Fullarton; John Morris; Massimo Di Pietro; Charles Gordon; Ian Penman; Hugh Barr; Praful Patel; Philip Boger; Neel Kapoor; Brinder Mahon; Jonathon Hoare; Ravi Narayanasamy; Dermot O'Toole; Edward Cheong; Natalie C Direkze; Yeng Ang; Marco Novelli; Matthew R Banks; Laurence Bruce Lovat Journal: Gastroenterology Date: 2013-03-28 Impact factor: 22.682
Authors: Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker Journal: Gut Date: 2013-10-28 Impact factor: 23.059